Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christoph Sippel"'
Autor:
Imke Ortland, Monique Mendel Ott, Michael Kowar, Christoph Sippel, Yon-Dschun Ko, Andreas H. Jacobs, Ulrich Jaehde
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background To evaluate medication-related risks in older patients with cancer and their association with severe toxicity during antineoplastic therapy. Methods This is a secondary analysis of two prospective, single-center observational stud
Externí odkaz:
https://doaj.org/article/e9af0fc72864439c866367e3968fd8f0
Autor:
Marcus Hentrich, Jordi Esteve, Matteo G. Della Porta, Mar Tormo, Sigrid Machherndl-Spandl, Ana Garrido, Sonia Matos, Annika Dufour, Olga Salamero, Jorge Sierra, Marta Pratcorona, Lisa Pleyer, Federico Lussana, Maria Carmo-Fonseca, Francesco Passamonti, Paola Fazi, Albertina Nunes, Sonja Heibl, Susana Vives, Christoph Sippel, Nicola Stefano Fracchiolla, Alfonso Piciocchi, Joana M. P. Desterro, Montserrat Arnan, Pamela Acha, Erica Travaglino, Aida Botelho de Sousa, Friedrich Stölzel, Maria Teresa Voso, Giulia Maggioni, Christian Thiede, Claudia Basilico, Cristina Astrid Tentori, Francesc Solé, Karsten Spiekermann, Marcos Lemos, Klaus H. Metzeler, Elisabetta Todisco, Bernhard Heilmeier, Jan Moritz Middeke, Marina Diaz, Valentina Mancini, David Gallardo
Publikováno v:
Blood. 136:30-31
Introduction. Mutations in genes encoding the metabolic enzymes isocitrate dehydrogenase (IDH) 1 and 2 are found in 10-20% of patients with acute myeloid leukemia (AML). Recently, IDH inhibitors have shown good clinical response in patient's refracto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b3e24f93ecaca5af9c5ef5f852005e2
https://doi.org/10.1182/blood-2020-140494
https://doi.org/10.1182/blood-2020-140494
Autor:
Michael Kowar, Monique Mendel Ott, Andreas H. Jacobs, Ulrich Jaehde, Yon-Dschun Ko, Imke Ortland, Christoph Sippel
Publikováno v:
Journal of geriatric oncology. 11(6)
Objectives To compare the CARG (Cancer and Aging Research Group) and CRASH (Chemotherapy Risk Assessment Scale for High-Age Patients) score regarding the predictive performance for severe toxicity in older patients with cancer. Methods We recruited p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08516d0f22b774ec6b8c0a1d88d7d067
https://pubmed.ncbi.nlm.nih.gov/31928942
https://pubmed.ncbi.nlm.nih.gov/31928942
Autor:
Anja Wallau, Peter Brossart, Young Kim, Ingo G.H. Schmidt-Wolf, Peter Walger, Christoph Sippel
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 141:1645-1651
Intensive therapy regimens in patients with acute myeloid leukemia (AML) frequently result in sepsis and septic shock. In this study, we investigated the prognostic outcome of AML patients requiring intensive care treatment due to severe sepsis or se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574fb38217bf3b40e2b15a1432dd0bdf
https://doi.org/10.1007/s00432-015-1955-9
https://doi.org/10.1007/s00432-015-1955-9
Publikováno v:
Hematological Oncology. 34:208-216
Immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, represent the basic principle of multiple myeloma treatment. However, the development of resistance is a limiting factor. Over the last years, the efficient applicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::047da96581d5913def22487f69e052a3
https://doi.org/10.1002/hon.2200
https://doi.org/10.1002/hon.2200
Publikováno v:
Hematological oncology. 34(4)
Immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, represent the basic principle of multiple myeloma treatment. However, the development of resistance is a limiting factor. Over the last years, the efficient applicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eac4bd2bf3754adb38857e5e0c33b04f
https://pubmed.ncbi.nlm.nih.gov/25784599
https://pubmed.ncbi.nlm.nih.gov/25784599